89 related articles for article (PubMed ID: 35899387)
1. Prevention and management of secondary central nervous system lymphoma.
Bobillo S; Khwaja J; Ferreri AJM; Cwynarski K
Haematologica; 2023 Mar; 108(3):673-689. PubMed ID: 36384246
[TBL] [Abstract][Full Text] [Related]
2. The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/
Lai A; Liu W; Wei H; Wang Y; Lin D; Zhou C; Liu B; Gu R; Li Y; Wei S; Gong B; Liu K; Gong X; Liu Y; Zhang G; Zhang J; Mi Y; Wang J; Qiu S
Blood Sci; 2024 Apr; 6(2):e00188. PubMed ID: 38742238
[TBL] [Abstract][Full Text] [Related]
3. Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study.
Zaliova M; Zuna J; Winkowska L; Janotova I; Skorepova J; Lukes J; Meyer C; Marschalek R; Novak Z; Domansky J; Stary J; Sramkova L; Trka J
Leukemia; 2024 Jan; 38(1):21-30. PubMed ID: 38001170
[TBL] [Abstract][Full Text] [Related]
4. Minimal Infiltrative Disease Identification in Cryopreserved Ovarian Tissue of Girls with Cancer for Future Use: A Systematic Review.
Grubliauskaite M; van der Perk MEM; Bos AME; Meijer AJM; Gudleviciene Z; van den Heuvel-Eibrink MM; Rascon J
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686475
[TBL] [Abstract][Full Text] [Related]
5. The MLL-Menin Interaction is a Therapeutic Vulnerability in
Rasouli M; Blair H; Troester S; Szoltysek K; Cameron R; Ashtiani M; Krippner-Heidenreich A; Grebien F; McGeehan G; Zwaan CM; Heidenreich O
Hemasphere; 2023 Aug; 7(8):e935. PubMed ID: 37520776
[TBL] [Abstract][Full Text] [Related]
6. NPM1-mutated acute myeloid leukemia: from bench to bedside.
Falini B; Brunetti L; Sportoletti P; Martelli MP
Blood; 2020 Oct; 136(15):1707-1721. PubMed ID: 32609823
[TBL] [Abstract][Full Text] [Related]
7. Analysis of rare driving events in pediatric acute myeloid leukemia.
Noort S; Oosterwijk JV; Ma J; Garfinkle EAR; Nance S; Walsh M; Song G; Reinhardt D; Pigazzi M; Locatelli F; Hasle H; Abrahamsson J; Jarosova M; Kelaidi C; Polychronopoulou S; Van den Heuvel-Eibrink MM; Fornerod M; Gruber TA; Zwaan CM
Haematologica; 2023 Jan; 108(1):48-60. PubMed ID: 35899387
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients.
De Clara E; Gourvest M; Ma H; Vergez F; Tosolini M; Dejean S; Demur C; Delabesse E; Recher C; Touriol C; Martelli MP; Falini B; Brousset P; Bousquet M
Haematologica; 2017 Oct; 102(10):1718-1726. PubMed ID: 28679652
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification.
Marcinkowska-Swojak M; Handschuh L; Wojciechowski P; Goralski M; Tomaszewski K; Kazmierczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
Mutat Res; 2016 Apr; 786():14-26. PubMed ID: 26894557
[TBL] [Abstract][Full Text] [Related]
12. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
13. Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators.
Fornerod M; Ma J; Noort S; Liu Y; Walsh MP; Shi L; Nance S; Liu Y; Wang Y; Song G; Lamprecht T; Easton J; Mulder HL; Yergeau D; Myers J; Kamens JL; Obeng EA; Pigazzi M; Jarosova M; Kelaidi C; Polychronopoulou S; Lamba JK; Baker SD; Rubnitz JE; Reinhardt D; van den Heuvel-Eibrink MM; Locatelli F; Hasle H; Klco JM; Downing JR; Zhang J; Pounds S; Zwaan CM; Gruber TA; ; ; ; ; ;
Blood Cancer Discov; 2021 Nov; 2(6):586-599. PubMed ID: 34778799
[TBL] [Abstract][Full Text] [Related]
14. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R
Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]